Pricing

Log inSign up

Renalytix

0 followers

‌

Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.

Industries

Biotechnology

Headquarters

New York, United States

Employees

51-200

Links

Org chart

JM
James McCullough
CEO
Collapse
Steven Coca
Co-Founder
Fergus Fleming
CTO
MD
Michael J. Donovan
Chief Medical Officer
Jed Fulk
Vice President Of Sales
Anna Flynn
Director, Quality System Compliance And Eh&s
Elise Wilfinger
Chief Strategy & Marketing Officer
KC
Kate Brennan, CFA
Senior Manager, Strategic Finance
Christopher Scott
Chief Operating Officer
Salim Hamir
Board Secretary

Board & advisors

CM
Christopher Mills
Non-Executive Director
EL
Erik Lium
Non-Executive Director
CP
Chirag R. Parikh
Non-Executive Director
Daniel J. Levangie
Non-Executive Director
TS
Timothy J. Scannell
Non-Executive Directors
Catherine Coste
Director

Teams

CP
CM
EL
+10

Management Team

14 people · 0 jobs

CW
+2

Healthcare and Clinical Science

6 people · 0 jobs

JM
MD

Leadership Team

3 people · 0 jobs

Sales Team

3 people · 0 jobs

AB

Product Management and Development Team

4 people · 0 jobs

Offices

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

157 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

Explore companies